Neuroinflammation: 2022 update

Authors

  • Hans Lassmann Center for Brain Research, Medical University of Vienna, Austria

DOI:

https://doi.org/10.17879/freeneuropathology-2022-3790

Keywords:

COVID-19, Multiple sclerosis, Alzheimer’s disease, Microglia, Neurodegeneration

Abstract

Besides important progress in the understanding of the pathological substrate of COVID-19-associated brain disease, major insights into mechanisms of neurodegeneration in human disease have been provided in neuropathological studies published in 2021. Recently developed techniques, which allow the simultaneous detection of a large battery of different molecules within single cells, have proven useful in the analysis of disease mechanisms in experimental and human neuroinflammatory conditions. They have elucidated protective and detrimental effects of activated microglia, which act in a stage and context-dependent manner in the induction and propagation of neurodegeneration. In addition, they emphasize the importance of synaptic damage and of selective neuronal vulnerability in the respective diseases. The results provide important new insights with high clinical relevance.

Metrics

PDF views
749
Feb 10 '22Feb 13 '22Feb 16 '22Feb 19 '22Feb 22 '22Feb 25 '22Feb 28 '22Mar 01 '22Mar 04 '22Mar 07 '22Mar 10 '2210
| |
HTML views
164
Feb 10 '22Feb 13 '22Feb 16 '22Feb 19 '22Feb 22 '22Feb 25 '22Feb 28 '22Mar 01 '22Mar 04 '22Mar 07 '22Mar 10 '2212
| |
Twitter
16
Jul 2022Jan 2023Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 202615
|

Downloads

Published

2022-02-10

How to Cite

Lassmann, H. (2022). Neuroinflammation: 2022 update. Free Neuropathology, 3, 3. https://doi.org/10.17879/freeneuropathology-2022-3790

Issue

Section

Reviews